| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/11/1994 | CA2105816A1 Substituted phenols, processes for their preparation and their use for the treatment of disorders caused by cell proliferation |
| 03/09/1994 | EP0586254A1 Furanoindoline derivatives and their use as antitumor agents |
| 03/09/1994 | EP0586026A2 Characterization of a novel anti-p110 RB monoclonal antibody |
| 03/09/1994 | EP0585986A1 Method and means for site directed therapy |
| 03/09/1994 | EP0585728A1 Use of dithiolylidene malonate derivatives for the prevention of metastasis |
| 03/09/1994 | EP0585570A1 Antigranulocyte antibody construct, preparation and use thereof |
| 03/09/1994 | EP0585444A1 Hepatoma treatment with somatostatin analogs |
| 03/09/1994 | EP0585399A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene |
| 03/09/1994 | EP0585364A1 Ctaa 81av78, the antigen recognized by human monoclonal antibody 81av78 |
| 03/09/1994 | EP0585337A1 Method of suppressing tumor formation in vivo by administering je/mlp-1 |
| 03/09/1994 | EP0585257A1 Dna and amino acid sequence specific for natural killer cells |
| 03/09/1994 | EP0437487B1 Targetting agents |
| 03/09/1994 | CN1083486A Heteroatoms-containing tricyclic compounds |
| 03/09/1994 | CN1083476A Quinoline derivative fumarates |
| 03/09/1994 | CN1083389A A novel anti-neoplastic cytokine |
| 03/08/1994 | US5292758 Sulfonamide derivatives |
| 03/08/1994 | US5292662 Position-specific insertion vectors and method of using same |
| 03/08/1994 | US5292650 Aerobic culture |
| 03/08/1994 | US5292513 Method for nonspecific cellular immune stimulation |
| 03/08/1994 | US5291896 Cardiac output probe assembly |
| 03/08/1994 | CA1327595C Biologically active carboxylic acid esters |
| 03/04/1994 | CA2105338A1 Furanoindoline derivatives |
| 03/03/1994 | WO1994004702A2 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | WO1994004694A1 Endothelial lineage specific transcriptional regulatory element from tek |
| 03/03/1994 | WO1994004679A1 Method for making humanized antibodies |
| 03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
| 03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
| 03/03/1994 | WO1994004670A1 Use of the cytokine ip-10 as an anti-tumor agent |
| 03/03/1994 | WO1994004561A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 03/03/1994 | WO1994004541A2 Protein kinase inhibitors and related compounds combined with taxol |
| 03/03/1994 | WO1994004535A1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same |
| 03/03/1994 | WO1994004534A1 Tetrahydropyrroloindole derivative, process for producing the same, and intermediates therefor |
| 03/03/1994 | WO1994004513A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | WO1994004512A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | WO1994004494A1 Tachykinin antagonists |
| 03/03/1994 | WO1994004180A2 Novel uses of il-4 and/or il-10, and antibodies against the same |
| 03/03/1994 | WO1994004178A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 03/03/1994 | WO1994004168A1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 03/03/1994 | WO1994004165A1 Antiangiogenic oligomers |
| 03/03/1994 | WO1994004162A1 Astragalus polysaccharide immunomodulators |
| 03/03/1994 | WO1994004159A2 Treatment of cancer with azt and alkylating or intercalating agents |
| 03/03/1994 | WO1994004147A1 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 03/03/1994 | WO1994004142A1 Novel metallocenes as anti-tumor drugs |
| 03/03/1994 | CA2143336A1 Tissue specific transcriptional regulatory element |
| 03/03/1994 | CA2142990A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 03/03/1994 | CA2142881A1 Detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | CA2142711A1 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 03/03/1994 | CA2142270A1 Astragalus polysaccharide immunomodulators |
| 03/03/1994 | CA2142110A1 Antiangiogenic oligomers |
| 03/03/1994 | CA2141939A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | CA2141938A1 Pharmaceutically active diketopiperazines |
| 03/03/1994 | CA2141602A1 Use of the cytokine ip-10 as an anti-tumor agent |
| 03/03/1994 | CA2141598A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 03/03/1994 | CA2140653A1 Protein kinase inhibitors and related compounds combined with taxol |
| 03/03/1994 | CA2140640A1 Tachykinin antagonists |
| 03/02/1994 | EP0585206A1 Tryptamines for treatment of circadian rhythm disorders |
| 03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
| 03/02/1994 | EP0585057A1 Lithium salts of fatty acids for the treatment of viral infections and cancer |
| 03/02/1994 | EP0584715A2 Isolation and culturing of transformed cells and preparation of antibodies against them |
| 03/02/1994 | EP0584694A1 Imidazolidin derivatives |
| 03/02/1994 | EP0584552A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 03/02/1994 | EP0584368A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584287A1 Use of müllerian inhibiting substance for treatment of certain tumors |
| 03/02/1994 | EP0584266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 03/02/1994 | EP0584256A1 Method for detecting an localizing tissues having neurokinine 1 receptors |
| 03/02/1994 | EP0584251A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth |
| 03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
| 03/02/1994 | EP0584208A1 Pyrrolidinones |
| 03/02/1994 | EP0584200A1 Trifluoromethyl analogs of fucose and uses thereof |
| 03/02/1994 | EP0584136A1 Determination of motifs of peptides on mhc molecules |
| 03/02/1994 | EP0509042B1 Pharmaceutical preparation of 1-Octadecyl-2-methyl-glycero-3-phosphocholin for intravenous administration |
| 03/02/1994 | EP0402378B1 Conjugation of polymer to colony stimulating factor-1 |
| 03/02/1994 | EP0266419B1 Fibrinolytic composition |
| 03/02/1994 | CN1083075A Linear peptides |
| 03/02/1994 | CN1083062A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 03/02/1994 | CN1023899C Production method of nutrition liquid |
| 03/01/1994 | US5290797 Benzopyran compounds |
| 03/01/1994 | US5290698 Streptoverticillium ferm P-10489 which produces antitumor agent BE-13793C |
| 03/01/1994 | US5290576 Antitumor polypeptide derivatives with iodine |
| 03/01/1994 | US5290554 Flowing extracting agent through bed of peat particles so that flow remains laminar |
| 03/01/1994 | CA1327358C Fluoro cytidine derivatives |
| 03/01/1994 | CA1327357C Antiviral, antitumor and antifungal compositions and their methods of use |
| 03/01/1994 | CA1327355C Amino anthracenediones-bis platinum complexes, useful as antitumoral agents |
| 03/01/1994 | CA1327353C Steroidesters from n-(2-halogenethyl)-n-nitroso- carbamoyl-amino-acids and their peptides, and method of producing the same |
| 02/26/1994 | CA2104764A1 Method for the safe administration of fatty acids |
| 02/26/1994 | CA2104747A1 Method for the safe administration of fatty acids |
| 02/23/1994 | EP0584034A2 Cytotoxic drug conjugates for treatment of neoplastic diseases |
| 02/23/1994 | EP0584001A1 Products containing taxol for use in cancer therapy |
| 02/23/1994 | EP0583794A1 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
| 02/23/1994 | EP0583572A1 (S)-2,3-Dihydropolyprenols and, (S)-2,3-dihydropolyprenyl monophosphates, method of preparation and use in inhibiting the metastasis of cancers |
| 02/23/1994 | EP0583394A1 Phosphite-borane compounds, and method of making and using the same |
| 02/23/1994 | CN1082541A Fluoro taxols |
| 02/22/1994 | CA1327200C Urea derivatives |
| 02/21/1994 | EP0594624A4 Dynemicin analogs: syntheses, methods of preparation and use. |
| 02/21/1994 | CA2101809A1 Cytotoxic drug conjugates for treatment of neoplastic diseases |
| 02/17/1994 | WO1994003644A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | WO1994003611A2 Ptp-d subfamily of protein tyrosine phosphatases |
| 02/17/1994 | WO1994003597A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 02/17/1994 | WO1994003475A1 FLUORINATED 17β-SUBSTITUTED 4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES |